Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor Agonists

This prospective observational study evaluates the longitudinal changes in anhedonia levels and emotional eating behaviors among adult individuals initiating glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight loss. Participants are assessed at baseline (treatment initiation) and after a 6-month follow-up period using standardized psychometric instruments.

Inclusion Criteria: * Age 18 years or older * Newly initiated on GLP-1 receptor agonist treatment for weight reduction * Willingness to participate in evaluations at baseline and at the 6-month follow-up * Ability to read and understand Turkish and possess the cognitive capacity to answer questionnaire items * Voluntary provision of written informed consent Exclusion Criteria: * Use of GLP-1 receptor agonists for indications other than weight loss * Cognitive, neurological, or severe psychiatric conditions preventing completion of self-report questionnaires * Substantial missing, inconsistent, or unverifiable questionnaire data compromising analysis integrity * Non-participation or dropout at the 6-month follow-up evaluation